A detailed history of Gladstone Institutional Advisory LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Gladstone Institutional Advisory LLC holds 25,683 shares of ABT stock, worth $2.65 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
25,683
Previous 17,882 43.62%
Holding current value
$2.65 Million
Previous $1.97 Million 48.32%
% of portfolio
0.16%
Previous 0.11%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$109.52 - $120.96 $854,365 - $943,608
7,801 Added 43.62%
25,683 $2.92 Million
Q4 2023

Feb 09, 2024

BUY
$90.19 - $110.4 $249,736 - $305,697
2,769 Added 18.32%
17,882 $1.97 Million
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $278,087 - $333,658
-2,911 Reduced 16.15%
15,113 $1.46 Million
Q2 2023

Aug 10, 2023

SELL
$100.78 - $112.29 $599,338 - $667,788
-5,947 Reduced 24.81%
18,024 $1.96 Million
Q1 2023

May 12, 2023

SELL
$96.86 - $114.01 $507,449 - $597,298
-5,239 Reduced 17.94%
23,971 $2.43 Million
Q4 2022

Feb 01, 2023

BUY
$95.06 - $111.52 $8,270 - $9,702
87 Added 0.3%
29,210 $3.21 Million
Q3 2022

Jan 27, 2023

BUY
$96.76 - $112.03 $227,386 - $263,270
2,350 Added 8.78%
29,123 $2.82 Million
Q3 2022

Oct 20, 2022

BUY
$96.76 - $112.03 $227,386 - $263,270
2,350 Added 8.78%
29,123 $2.82 Million
Q2 2022

Jan 27, 2023

BUY
$102.07 - $123.37 $1.37 Million - $1.65 Million
13,377 Added 99.86%
26,773 $2.91 Million
Q2 2022

Aug 15, 2022

BUY
$102.07 - $123.37 $1.37 Million - $1.65 Million
13,377 Added 99.86%
26,773 $2.91 Million
Q1 2022

Jan 27, 2023

SELL
$114.02 - $139.04 $67,955 - $82,867
-596 Reduced 4.26%
13,396 $1.59 Million
Q1 2022

May 04, 2022

SELL
$114.02 - $139.04 $67,955 - $82,867
-596 Reduced 4.26%
13,396 $1.59 Million
Q4 2021

Jan 27, 2023

BUY
$115.53 - $141.46 $51,295 - $62,808
444 Added 3.28%
13,992 $1.97 Million
Q4 2021

Feb 11, 2022

BUY
$115.53 - $141.46 $51,295 - $62,808
444 Added 3.28%
13,992 $1.97 Million
Q3 2021

Jan 27, 2023

BUY
$116.66 - $129.06 $340,647 - $376,855
2,920 Added 27.47%
13,548 $1.6 Million
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $340,647 - $376,855
2,920 Added 27.47%
13,548 $1.6 Million
Q2 2021

Jan 27, 2023

BUY
$105.79 - $124.53 $916,458 - $1.08 Million
8,663 Added 440.87%
10,628 $1.23 Million
Q2 2021

Aug 13, 2021

BUY
$105.79 - $124.53 $916,458 - $1.08 Million
8,663 Added 440.87%
10,628 $1.23 Million
Q1 2021

Jan 27, 2023

SELL
$108.84 - $128.23 $2.96 Million - $3.48 Million
-27,158 Reduced 93.25%
1,965 $236,000
Q1 2021

May 17, 2021

BUY
$108.84 - $128.23 $213,870 - $251,971
1,965 New
1,965 $236,000
Q3 2019

Nov 13, 2019

SELL
$81.84 - $88.74 $195,188 - $211,644
-2,385 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$72.88 - $85.0 $173,818 - $202,725
2,385 New
2,385 $201,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $181B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Gladstone Institutional Advisory LLC Portfolio

Follow Gladstone Institutional Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gladstone Institutional Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gladstone Institutional Advisory LLC with notifications on news.